
|Articles|February 9, 2022
Webinar: The Necessity of Extractables & Leachables Qualifications for Lyophilized Drug Products
Author(s)Nelson Labs
When selecting and qualifying the primary packaging for lyophilized drug products (LDPs), one of the obvious questions is How far should one go into the E&L-qualification process? As the drug product is in a solid state, one would expect that the interaction between the LDP and the components of its container would be low. But is this really the case? Watch this webinar to learn more.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
4
Johnson & Johnson’s Tecvayli Combo Wins FDA National Priority Voucher
5